Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Purpose To investigate whether the blood-brain barrier (BBB) leaks blood-circulating substances in patients with early forms of Alzheimer disease (AD), and if so, to examine the extent and pattern of leakage. Materials and Methods This study was approved by the local medical ethical committees of the Maastricht University Medical Center and Leiden University Medical Center, and written informed consent was obtained from all subjects. For this pilot study, 16 patients with early AD and 17 healthy age-matched control subjects underwent dynamic contrast material–enhanced magnetic resonance (MR) imaging sequence with dual time resolution for 25 minutes. The Patlak graphical approach was used to quantify the BBB leakage rate and local blood plasma volume. Subsequent histogram analysis was used to determine the volume fraction of the leaking brain tissue. Differences were assessed with linear regression analysis, adjusted for confounding variables. Results The BBB leakage rate was significantly higher in patients compared with that in control subjects in the total gray matter (P < .05) and cortex (P = .03). Patients had a significantly higher volume fraction of the leaking brain tissue in the gray matter (P = .004), normal-appearing white matter (P < .04), deep gray matter (P = .01), and cortex (P = .004). When all subjects were considered, scores on the Mini-Mental State Examination decreased significantly with increasing leakage in the deep gray matter (P = .007) and cortex (P < .05). Conclusion The results of this study showed global BBB leakage in patients with early AD that is associated with cognitive decline. A compromised BBB may be part of a cascade of pathologic events that eventually lead to cognitive decline and dementia. ©RSNA, 2016 Online supplemental material is available for this article. An earlier incorrect version of this article appeared online. This article was corrected on October 24, 2016.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent neuroimaging studies in individuals with mild cognitive impairment (MCI) and early AD reveal BBB breakdown in the hippocampus, including its CA1 and dentate gyrus subfields (421), and several gray and white matter regions (220-222), respectively, before brain atrophy and dementia.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [220]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“BBB leakiness is seen both with normal ageing and AD [124,125].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [125]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the BBB disruption and increased permeability have been shown to occur in the early phase of the AD pathology (van de Haar et al., 2016).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as van de Haar et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Research works printed but not linked: 1
- Butman J, 2006, Proceedings of the Fourteenth Meeting of the International Society for Magnetic Resonance in Medicine, 1535
Cited by
Items 401–500 of 653
Taghvaei, M., Mechanic-Hamilton, D. J., Sadaghiani, S., Shakibajahromi, B., Dolui, S., Das, S. R., Brown, C. D., Tackett, W., Khandelwal, P., Cook, P. A., et al. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.10.012 · Cited by 13
Farias, H. R., Beber, L. C. C., Guma, F. T. C. R., & de Oliveira, J. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01620-y · Cited by 13
“…BBB breakdown, closely related to the passage of dangerous and inflammatory molecules to the brain and negative consequences to the cognitive capacity (Zhao et al. 2015; Sweeney et al. 2018; Haruwaka et al. 2019), as proved clinically (Zlokovic 2011 ; Montagne et al. 2015; van de Haar et al. 2016).”
Shi, M., Li, C., Tian, X., Chu, F., & Zhu, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.685863 · Cited by 13
Sanders, O. D. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220047 · Cited by 13
Jang, M., Choi, S.-H., Choi, J. H., Oh, J., Lee, R., Lee, N.-E., Cho, Y., Rhim, H., Kim, H., Cho, I., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9741 · Cited by 13
Taccola, C., Barnéoud, P., Cartot‐Cotton, S., Valente, D., Schussler, N., Saubaméa, B., Chasseigneaux, S., Cochois, V., Mignon, V., Curis, E., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108588 · Cited by 13
Unfolded p53 in non-neuronal cells supports bacterial etiology of Alzheimer’s disease
French, P. W. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.339476 · Cited by 13
Ashok, C., Kimble, A. L., Tyburski, J. D., Leclair, N. K., Zuberi, A. R., Murphy, M., Jellison, E. R., Reese, B., Hu, X., Lutz, C. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.13.571184 · Cited by 13
Pros and Cons of Human Brain Organoids to Study Alzheimer’s Disease
Sainz, A., Pérez-Cerdá, F., Pérez‐Samartín, A., Panicker, M. M., Ruiz, A., & Matute, C. (2024) · Aging and Disease · doi:10.14336/ad.2024.1409 · Cited by 12
Nozohouri, E., Noorani, B., Patel, D., Ahn, Y., Zoubi, S., & Bickel, U. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00685-2 · Cited by 12
Verstappen, D., de Jong, J. J. A., Voorter, P., van Dinther, M., van Oostenbrugge, R. J., Staals, J., Jansen, J. F. A., & Backes, W. H. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251364151 · Cited by 12
Self-citationCognitive Deficits in Type-1 Diabetes: Aspects of Glucose, Cerebrovascular and Amyloid Involvement
Pickering, J., Wong, R. H. X., Al‐Salami, H., Lam, V., & Takechi, R. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03100-1 · Cited by 12
Sharma, H. S., Muresanu, D. F., Nozari, A., Lafuente, J. V., Buzoianu, A. D., Sahib, S., Tian, Z. R., Bryukhovetskiy, I., Manzhulo, I., Menon, P. K., et al. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.04.008 · Cited by 12
Parillo, M., Mallio, C. A., Dekkers, I. A., Rovira, À., van der Molen, A. J., Quattrocchi, C. C., & The ESMRMB-GREC Working Group (2024) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-024-01151-0 · Cited by 12
Haghdel, A., Smith, N. M., Glodzik, L., Li, Y., Wang, X. H., Crowder, T., Zhu, Y., Butler, T., Blennow, K., McIntire, L. B., et al. (2024) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000623 · Cited by 12
O’Hare, N. R., Millican, K., & Ebong, E. E. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1394725 · Cited by 12
Waller, E. S., Yardeny, B. J., Fong, W. Y., Gan, X. Y., Jimenez, S. V., Pan, Y., Abasszade, J. H., & Nicolazzo, J. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114282 · Cited by 12
Neuropathological links between T2DM and LOAD: systematic review and meta-analysis
Lemche, E., Hortobágyi, T., Kiecker, C. M., & Turkheimer, F. (2025) · Physiological Reviews · doi:10.1152/physrev.00040.2024 · Cited by 11
Abedin, M. J., & Kastanenka, K. V. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251411561 · Cited by 11
Blood–brain barrier water exchange measurements using contrast‐enhanced ASL
Powell, E., Dickie, B., Ohene, Y., Maskery, M. P., Parker, G. J. M., & Parkes, L. M. (2023) · NMR in Biomedicine · doi:10.1002/nbm.5009 · Cited by 11
Thrombotic Thrombocytopenic Purpura with Concomitant Progressive Cerebral Microbleeds
Noorbakhsh-Sabet, N., & Zand, R. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.08.037 · Cited by 11
Ishihara, K., Takata, K., & Mizutani, K. (2023) · Life · doi:10.3390/life13010221 · Cited by 11
Fang, X. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0239-x · Cited by 11
Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer’s Disease
Wheeler, K. V., Irimia, A., & Braskie, M. N. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230553 · Cited by 10
Solders, S. K., Shen, Q., & Reas, E. T. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103805 · Cited by 10
Schindler, K. A., Torices, S., Schurhoff, N. A., Gallo, D. I., & Toborek, M. J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115645 · Cited by 10
Rudnitskaya, E. A., Kozlova, T., Burnyasheva, A. O., Peunov, D., Tyumentsev, M., Stefanova, N. A., & Kolosova, N. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115649 · Cited by 10
Nam, Y., Ji, Y., Shin, S. J., Park, H. H., Yeon, S.-H., Kim, S.-Y., Son, R. H., Jang, G. Y., Kim, H. D., & Moon, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117090 · Cited by 10
Mapping the Glymphatic Pathway Using Imaging Advances
Thakkar, R. N., Kioutchoukova, I. P., Griffin, I. T., Foster, D. T., Sharma, P., Valero, E. M., & Lucke-Wold, B. P. (2023) · J — Multidisciplinary Scientific Journal · doi:10.3390/j6030031 · Cited by 10
Bolourian, A., & Mojtahedi, Z. (2017) · Immunotherapy · doi:10.2217/imt-2016-0137 · Cited by 10
Clearance of amyloid plaque via focused ultrasonication in a mouse model of Alzheimer's disease
Lee, S., Kum, J., Kim, K., Park, T. Y., Ko, H., Na, D. L., Kang, S. Y., Kim, H., Kim, Y. S., & Kim, J. (2025) · Theranostics · doi:10.7150/thno.122123 · Cited by 9
The Role of Oligodendrocyte Lineage Cells in the Pathogenesis of Alzheimer’s Disease
Liu, X., Lv, Z., Huang, Q., Lei, Y., Liu, H., & Xu, P. (2025) · Neurochemical Research · doi:10.1007/s11064-024-04325-3 · Cited by 9
Enlarged perivascular spaces are associated with decreased brain tau deposition
Kang, K. M., Byun, M. S., Yi, D., Lee, K. H., Kim, M. J., Ahn, H., Jung, G., Lee, J., Kim, Y. K., Lee, Y., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14040 · Cited by 9
McCaulley, M. E., & Grush, K. A. (2017) · International Journal of Alzheimer s Disease · doi:10.1155/2017/2438901 · Cited by 9
Houben, S., de Fisenne, M.-A., Ando, K., Dries, V. V., Poncelet, L., Yilmaz, Z., Mansour, S., Decker, R. D., Brion, J., & Leroy, K. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00106 · Cited by 9
Biorobotic Drug Delivery for Biomedical Applications
Le, Q., & Shim, G. (2024) · Molecules · doi:10.3390/molecules29153663 · Cited by 8
Yao, M., Sun, N., Linville, R. M., Wei, Z., Kakazu, A., Ouyang, Y., Li, R., Du, L., Wang, H., Zhou, Y., et al. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00756-4 · Cited by 8
van der Panne, S. A., Durrant, H., Heuer, J. F., Kancheva, I. K., Stellingwerf, A., Verkaar, L., Verstappen, D., Mossel, P., Backes, W. H., Bakker, E. N. T. P., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71263 · Cited by 9
Self-citationQuantitative Trait Module-Based Genetic Analysis of Alzheimer’s Disease
Yuan, S., Li, H., Xie, J., & Sun, X. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235912 · Cited by 8
Virtuoso, A., Colangelo, A. M., Maggio, N., Fennig, U., Weinberg, N., Papa, M., & Luca, C. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111304 · Cited by 8
Bae, J., Li, C., Masurkar, A. V., Ge, Y., & Kim, S. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120284 · Cited by 8
“5 the older healthy cohort reported permeability values that differed by several orders of magnitude, ranging from 10e-3 to 10e-7 mm-1 [13, 14, 17].”
BackgroundMethodInfluentialPark, J. S., Lim, E., Choi, S.-H., Sohn, C., Lee, J., & Park, J. (2019) · Medical Image Analysis · doi:10.1016/j.media.2019.101566 · Cited by 8
Can Porphyromonas gingivalis Contribute to Alzheimer’s Disease Already at the Stage of Gingivitis?
Olsen, I. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210006 · Cited by 8
“Cytokines, chemokines, signal transduction molecules, and lipopolysaccharide (LPS) are implicated in BBB dysfunction in response to systemic inflammation [12], and a global BBB leakage has been demonstrated in patients with early AD associated with cognitive decline [13].”
BackgroundMethylated Ccfdna from Plasma Biomarkers of Alzheimer’s Disease Using Targeted Bisulfite Sequencing
Guemri, J., Pierre‐Jean, M., Brohard, S., Oussada, N., Horgues, C., Bonnet, É., Mauger, F., & Deleuze, J. (2022) · Epigenomics · doi:10.2217/epi-2021-0491 · Cited by 8
Saleh, M. A. A., Bloemberg, J. S., Elassaiss‐Schaap, J., & de Lange, E. C. M. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03281-3 · Cited by 8
Oh, G., Moon, Y., Moon, W., & Ye, J. C. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120571 · Cited by 8
Jin, S., Wu, X., Zhang, Y., Xu, F., Zhen, W., Sun, Y., Pan, Y., Lu, Y., Yang, Y., Sun, W., et al. (2026) · hLife · doi:10.1016/j.hlife.2026.03.001 · Cited by 7
Dysfunction of the neurovascular unit as a temporal driver in Alzheimer’s pathogenesis
Wang, L., Han, L., & Liu, S. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00548-2 · Cited by 7
Altered Clearance in Alzheimer's Disease and Cerebral Amyloid Angiopathy
Mohammadi, S., Dolatshahi, M., Rahmani, F., & Raji, C. A. (2025) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2024.12.004 · Cited by 7
Moussiopoulou, J., & Falkai, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-81802-8_4 · Cited by 7
MRI detects blood-brain barrier alterations in a rat model of Alzheimer’s disease and lung infection
Ohene, Y., Morrey, W. J., Powell, E., Smethers, K. F., Luka, N., South, K., Berks, M., Lawrence, C. B., Parker, G. J. M., Parkes, L. M., et al. (2025) · npj Imaging · doi:10.1038/s44303-025-00071-5 · Cited by 7
“Dynamic contrast-enhanced (DCE) MRI has been used to measure early BBB disruption in Alzheimer ’ s disease by monitoring leakage of gadolinium-based contrast agents 19,32,33 , but requires careful implementation when probing subtle leakage 34 – 37 .”
Experimental tooth loss affects spatial learning function and blood–brain barrier of mice
Oue, H., Hatakeyama, R., Ishida, E., Yokoi, M., & Tsuga, K. (2022) · Oral Diseases · doi:10.1111/odi.14379 · Cited by 7
Role of Microbiota in Neurodegenerative Diseases
Sobol, C. V. (2018) · Russian Journal of Developmental Biology · doi:10.1134/s1062360418060061 · Cited by 7
“The translocation of toxic microbiota products through weakened protective barriers (blood-brain RUSSIAN JOURNAL OF D and GI mucosa) can be critical in neurodegenerative diseases (Montagne et al., 2015; van de Haar et al., 2016; Varatharaj and Galea, 2017).”
BackgroundStephen, R. (2020) · UEF eRepo (University of Eastern Finland) · Cited by 7
Sobhan, R. (2020) · UEA Digital Repository (University of East Anglia) · Cited by 7
Yin, H., Lu, Z., Deng, Y., Tian, X., & Gong, Q. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102952 · Cited by 6
van Setten, A., Uleman, J. F., Melis, R. J. F., LAWLOR, B. A., Riksen, N. P., Claassen, J. A. H. R., de Heus, R. A. A., on behalf of NILVAD Study Group, Segurado, R., Kennelly, S., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01294-x · Cited by 6
Self-citationTaoka, T., Iwamoto, K., Miyata, S., Ito, R., Nakamichi, R., Nakane, T., Okada, I., Ichikawa, K., Kan, H., Kamagata, K., et al. (2025) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.mp.2024-0176 · Cited by 6
Cai, M., Cai, K., Wei, Z., Zhou, J., Shu, J., Wang, W., Sun, W., & Hu, J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1632365 · Cited by 6
Stringer, M. S., Shao, X., Lee, H., Vallatos, A., Arteaga, C., Clancy, Ú., Chappell, F. M., Manning, C., Valdés-Hernández, M. C., García, D. J., et al. (2026) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2026.100528 · Cited by 6
“In this small study, we found evidence of associations between DW-ASL and GBCA BBB function metrics. k w was sensitive to SVD severity and 1-year change, consistent with previous studies using GBCA [5,6,30, 45,46], suggesting DW-ASL is a promising imaging marker of subtle BBB dysfunction.”
Emblem, K. E., Larsson, C., Groote, I. R., & Bjørnerud, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-48419-4_11 · Cited by 6
Advances in modeling permeability and selectivity of the blood-brain barrier using microfluidics
Sun, J., & Song, S. (2024) · Microfluidics and Nanofluidics · doi:10.1007/s10404-024-02741-z · Cited by 6
“…endfeet are frequently observed after a stroke, accompanied with increased endothelial vesicles (Haley and Lawrence 2017; Ito et al. 2011); early Alzheimer’s patients exhibit global BBB leakage followed by cognitive decline and eventual dementia (Van De Haar et al. 2016; Nehra et al. 2022).”
Janus, A., Dumas, D., Douce, J. L., Marie, S., Pasculli, G., Bambury, P., Lemarchant, S., Kremer, P. H. C., & Godfrin, Y. (2024) · Neurology and Therapy · doi:10.1007/s40120-024-00691-w · Cited by 6
A free time point model for dynamic contrast enhanced exploration
Julie, L., Ikram, D., Pérez-Liva, M., Lecler, A., Bouchouicha, A., Sourdon, J., Bentoumi, I., Cuénod, C. A., & Balvay, D. (2021) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2021.04.005 · Cited by 6
Du, M., Wang, X., Ma, F., Li, F., Li, H., Li, F., Zhang, A., & Gao, Y. (2022) · Journal of Cardiac Surgery · doi:10.1111/jocs.16248 · Cited by 6
The glymphatic system in the brain — neurobiology and clinical pathology
Ai, F. (2023) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202312305113 · Cited by 5
Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer’s disease
Dan, Y. R., & Chiam, K. (2024) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2024.1463001 · Cited by 5
An arrayed CRISPR knockout screen identifies genetic regulators of GLUT1 expression
Shi, Y., Katdare, K. A., Kim, H., Rosch, J. C., Neal, E. H., Vafaie-Partin, S., Bauer, J. A., & Lippmann, E. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-48361-5 · Cited by 5
Aged human serum induces vascular changes in an isogenic co-culture venule model
Chung, T. D., Linville, R. M., Zhao, N., Wang, L., Xia, Z., & Searson, P. C. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102544 · Cited by 5
Alzheimer Dementia and Microvascular Pathology: Blood-Brain Barrier Permeability Imaging
Moon, W. (2020) · Journal of the Korean Society of Radiology · doi:10.3348/jksr.2020.81.3.488 · Cited by 5
Festoff, B. W., & Dockendorff, C. (2021) · Biomolecules · doi:10.3390/biom11111558 · Cited by 5
Chen, Y., Huang, X.-M., Chen, H., & Yi, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33077 · Cited by 5
Tan, A. Y. S., Martinez, L. C. M. G., Murray, H. C., Mehrabi, N. F., Tippett, L. J., Turner, C. P., Curtis, M. A., Faull, R. L. M., Dragunow, M., & Singh‐Bains, M. K. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106829 · Cited by 5
Chronic Fatigue Syndrome (CFS) or “Systemic Immune Disorder” (SID)?
Comhaire, F. H., & Devriendt, G. (2016) · Internal Medicine Open Access · doi:10.4172/2165-8048.1000225 · Cited by 5
Blood-Brain Barrier Leakage in Early Alzheimer Disease
Lecler, A., Fournier, L. S., Diard‐Detoeuf, C., & Balvay, D. (2017) · Radiology · doi:10.1148/radiol.2017162578 · Cited by 5
Brain lymphatic drainage system – visualization opportunities and current state of the art
Yankova, G., & Bogomyakova, O. B. (2020) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2020-9-3-81-89 · Cited by 5
‘A picture is worth a thousand words’: The use of microscopy for imaging neuroinflammation
de Fraga, L. S., Tassinari, I. D., Jantsch, J., Guedes, R. P., & Bambini-Júnior, V. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13669 · Cited by 5
Edwards, L., Gonzalez, A. I., Thomas, K. R., Smirnov, D. S., Brenner, E. K., Nation, D. A., Chang, F., Blennow, K., Salmon, D. P., Galasko, D., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70910 · Cited by 4
Blood-brain barrier water exchange in relation to amyloid, cognition and cerebrovascular burden
Padrela, B. E., Tecelão, S. R. R., Kirsebom, B., Geier, O. M., Tranfa, M., Masserini, F., Sneve, M. H., Slivka, M., FALCH, E., Pålhaugen, L., et al. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103926 · Cited by 4
“…our findings are in line with the results of previous contrast agent-based imaging techniques, which reported altered BBB permeability in MCI participants (Sweeney et al., 2018; van de Haar, 2016), despite the molecular size difference between the tracers (cid:0) gadolinium and blood water.”
Barron, A. E., Lin, J. S., Ryder, M. I., & Bergman, P. N. (2025) · Journal of Internal Medicine · doi:10.1111/joim.70060 · Cited by 4
Hills, C., Hernandez, C. A., Gabbay, V., & Berman, J. W. (2026) · Cells · doi:10.3390/cells15050399 · Cited by 4
Denkinger, M. N., Baker, S. L., Harrison, T. M., Chadwick, T. A., & Jagust, W. J. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.11.002 · Cited by 4
Merbl, Y., Mondrus, E., Hanael, E., & Shamir, M. H. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1572286 · Cited by 4
Lu, Z., Yin, H., Xiang, P., Yi, X., Tian, X., & Gong, Q. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70237 · Cited by 4
Christodoulou, R. C., Vamvouras, G., Sarquis, M. D., Petrou, V., Papageorgiou, P. S., Rivera, L., Gonzalez, C. M., Rivera, G., Papageorgiou, S. G., & Vassiliou, E. K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207360 · Cited by 4
Power, L., Friedman, A., & Bardouille, T. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.01.009 · Cited by 4
Developmental priming of early cerebrovascular ageing: Implications across a lifetime
Stolp, H. B., & Solito, E. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.6090 · Cited by 4
da Silva, A. F., Gomes, A., Gonçalves, L., Fernandes, A. M. A., & Almeida, A. J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020141 · Cited by 4
Report on the Myomatrix Conference April 22–24, 2012, University of Nevada, Reno, Nevada, USA
Rutkowski, A., Bönnemann, C. G., Brown, S., Þorsteinsdóttir, S., Dominov, J. A., Rüegg, M. A., Matter, M. L., Guttridge, D. C., Crosbie, R. H., Kardon, G., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.06.353 · Cited by 4
Chen, W., Barback, C. V., Wang, S., Hoh, C. K., Chang, E. Y., Hall, D. J., Head, B. P., & Vera, D. R. (2020) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.02.013 · Cited by 4
Multifactorial glial responses and their contributions to Alzheimer's disease continuum
Hijioka, M., Manabe, T., & Saito, T. (2023) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12745 · Cited by 4
De, D., Bhattacharjee, P., Das, H., Kumar, K. S., Biswas, S. C., & Bhattacharyya, D. (2020) · FEBS Journal · doi:10.1111/febs.15149 · Cited by 4
Chang, R., Maghribi, A. A., Vanderpoel, V., Vasilevko, V., Cribbs, D. H., Boado, R. J., Pardridge, W. M., & Sumbria, R. K. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01211 · Cited by 4
Zhu, Y. D., Lee, Q. N., Shao, X., Jung, Y., Wang, D. J. J., & Fan, A. P. (2025) · Magnetic Resonance in Medicine · doi:10.1002/mrm.70081 · Cited by 3
Belaidi, A. A., Furtado, D. L., Alves, F. M., Nisbet, R. M., Ayton, S., & Bush, A. I. (2026) · Exploration · doi:10.1002/exp2.70223 · Cited by 4
Voigt, S., de Jong, J., Voorter, P., Koemans, E. A., Schipper, M. R., van der Plas, M. C., Kaushik, K., van der Zwet, R. G. J., van Dort, R., van den Brink, H., et al. (2026) · International Journal of Stroke · doi:10.1177/17474930261424089 · Cited by 3
Self-citationElevated levels of circulating plasma sPDGFRβ in cognitively impaired APOE4 carriers
Sagare, A. P., Lohman, T., Ramirez, I., Joe, E., Harrington, M. G., Chui, H. C., Schneider, L. S. S., Yassine, H. N., Ringman, J. M., Toga, A. W., et al. (2026) · GeroScience · doi:10.1007/s11357-026-02291-y · Cited by 3
Gadolinium-Based Imaging and the Study of Neurofluid Dynamics
Ringstad, G. A., Eide, P. K., Naganawa, S., & Agarwal, N. (2025) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2024.12.008 · Cited by 3
Petitclerc, L., Durrant, H., Hirschler, L., Václavů, L., & van Osch, M. J. P. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261429042 · Cited by 3
Analysis the alteration of systemic inflammation in old and young APP/PS1 mouse
Liu, L., Cao, J., Huang, C., Yuan, E., & Ren, J. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111274 · Cited by 3
Metadata
- Authors
- van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H.
- Affiliations
- Maastricht University Medical Centre (NL)
- Leiden University Medical Center (NL)
- Leiden University (NL)
- ORCID
- Venue
- Radiology
- Published
- 2016-11
- Volume
- 281
- Issue
- 2
- Pages
- 527-535
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2415637550
- Cited by
- 601
- References
- 32
- Citations by year
- 2026: 37 · 2025: 56 · 2024: 66 · 2023: 65 · 2022: 81 · 2021: 89 · 2020: 64 · 2019: 50 · 2018: 42 · 2017: 36 · 2016: 13
- FWCI
- 25.63
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Radiology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Radiological Society of North America
- Internationale Stichting Alzheimer Onderzoek (10553)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- blood-brain barrier disruption, early Alzheimer's disease, dynamic contrast-enhanced MRI, Patlak graphical analysis, plasma volume, gray matter, normal-appearing white matter, deep gray matter, cognitive decline, Mini-Mental State Examination
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Blood Volume, Blood-Brain Barrier, Contrast Media, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Pilot Projects, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.